How is mental health care provided through community pharmacies? A quest for improvement

Main Article Content


Mental health, Community pharmacy services, Pharmacists, Attitude, Professional practice


Background: Mental disease burden is increasing globally, and a substantial shortage of mental health professionals remains. Community pharmacists can improve population mental health outcomes to bridge the mental health care gap. However, there is a paucity of data on community pharmacists’ provision of mental health care. Objective: To assess community pharmacist-delivered care to people with mental illness in the United Arab Emirates (UAE), focusing on dispensing and counseling practices, pharmacists’ confidence and comfort in providing care, and attitudes and beliefs towards mental illness. Methods: This was a mixed-methods study with an exploratory, sequential design. Semi-structured interviews explored community pharmacists’ practices, challenges and strategies to improve care. Data were analyzed thematically, and the results guided questionnaire development. The questionnaire was also informed by the Framework of Core Mental Health Competencies for All Pharmacy Professionals and other relevant literature and administered to community pharmacists in four out of seven emirates. Logistic regression was used to identify the predictors of pharmacist practices. Results: In the interviews, community pharmacists described adopting a precautionary attitude and perceived their role as a dispensing one. They reported challenges such as emotional discomfort and lack of training but highlighted the need for a different approach to patients with mental illness. In total, 252 pharmacists completed the questionnaire, and 74% reported performing at least five counseling practices. Logistic regression showed that pharmacists who performed a higher number of practices (≥5) were younger, received continuing education on mental health care in the last two years, and had higher confidence levels. Conclusion: UAE community pharmacists performed basic dispensing practices and reported discomfort during encounters with patients with mental illness. Training on patient-centered communication skills and psychiatric therapeutics is needed to improve pharmacist-delivered services, alongside increased collaboration with other providers and services.


Download data is not yet available.
Abstract 761 | PDF Downloads 438


1. GBD 2019 Mental Disorders Collaborators. Global, regional and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiat. 2022;9(2):137-150.
2. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiat. 2016;3(2):171-178.
3. Santomauro DF, Mantilla Herrera AM, Shadid J, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700-1712.
4. Nochaiwong S, Ruengorn C, Thavorn K, et al. Global prevalence of mental health issues among the general population during the coronavirus disease-2019 pandemic: a systematic review and meta-analysis. Sci Rep. 2021;11(1):1-18.
5. World Health Organization. Mental Health. Accessed December 27, 2021.
6. Dattani S, Ritchie H, Roser M. Mental Health. 2021. Accessed December 26, 2021.
7. World Health Organization. Global Health Observatory Data Repository: Mental Health: Human Resources: Data by Country; 2019. Accessed December 27, 2021.
8. Daradkeh TK, Eapen V, Ghubash R. Mental morbidity in primary care in Al Ain (UAE): Application of the Arabic translation of the PRIME-MD (PHQ) version. Ger J Psychiatry. 2005;8(3):32-35.
9. Haque A. Mental health laws and reflections on culture: The case of United Arab Emirates. J Muslim Ment Health. 2020;14(1):37-48.
10. Karam EG, Karam GE, Farhat C, et al. Determinants of treatment of mental disorders in Lebanon: Barriers to treatment and changing patterns of service use. Epidemiol Psychiatr Sci. 2018;28(6):655-661.
11. Ali SH, Agyapong VIO. Barriers to mental health service utilisation in Sudan - Perspectives of carers and psychiatrists Health systems and services in low and middle income settings. BMC Health Serv Res. 2016;16(1):1-10.
12. World Health Organization. Comprehensive Mental Health Action Plan 2013-2030. Geneva: World Health Organization. 2021.
13. Bulloch AGM, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):47-56.
14. Hampton LM, Daubresse M, Chang H-Y, et al. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry. 2014;71(9):1006-1014.
15. Davis B, Qian J, Ngorsuraches S, et al. The clinical impact of pharmacist services on mental health collaborative teams: A systematic review. J Am Pharm Assoc. 2020;60(5):S44-S53.
16. Capoccia KL, Boudreau DM, Blough DK, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Heal Pharm. 2004;61(4):364-372.
17. McMillan SS, Kelly F, Hattingh HL, et al. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes. J Ment Health. 2018;27(2):164-173.
18. Brown JVE, Walton N, Meader N, et al. Pharmacy-based management for depression in adults. Cochrane database Syst Rev. 2019;12(12):CD013299.
19. Brook O, Van Hout H, Nieuwenhuyse H, et al. Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial. Eur Neuropsychopharmacol. 2003;13(1):1-9.
20. Aljumah K, Hassali MA. Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study. BMC Psychiatry. 2015;15(1):219.
21. Al-Saffar N, Abdulkareem A, Abdulhakeem A, et al. Depressed patients’ preferences for education about medications by pharmacists in Kuwait. Patient Educ Couns. 2008;72(1):94-101.
22. Miller P, Newby D, Walkom E, et al. Depression screening in adults by pharmacists in the community: a systematic review. Int J Pharm Pract. 2020;28(5):428-440.
23. Crump K, Boo G, Liew FS, et al. New Zealand community pharmacists’ views of their roles in meeting medicine-related needs for people with mental illness. Res Soc Adm Pharm. 2011;7(2):122-133.
24. Ministry of Health and Prevention. Federal Law No. (8) of Year 2019 On Medical Products, the Profession of Pharmacy, and Pharmaceutical Facilities. 2019.
25. Hasan S, Sulieman H, Chapman CB, et al. Community pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2012;20(4):218-225.
26. Alzubaidi H, Saidawi W, Mc Namara K. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates. Int J Clin Pharm. 2018;40:1106-1115.
27. Alzubaidi H, Hasan S, Saidawi W, et al. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country. Diabet Med. 2021;38(8):e14598.
28. Cates ME, Burton AR, Woolley TW. Attitudes of pharmacists toward mental illness and providing pharmaceutical care to the mentally ill. Ann Pharmacother. 2005;39(9):1450-1455.
29. Scheerder G, De Coster I, Van Audenhove C. Community pharmacists’ attitude toward depression: A pilot study. Res Soc Adm Pharm. 2009;5(3):242-252.
30. Giannetti V, Caley CF, Kamal KM, et al. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. Int J Clin Pharm. 2018;40(5):1096-1105.
31. Shami R, Alam MF, ElHajj MS. The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers. Int J Clin Pharm. 2022;44:214-226.
32. Creswell JW. Designing and Conducting Mixed-Methods Research. 2nd ed. SAGE Publications Ltd STM; 2011.
33. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77-101.
34. Mey A, Fowler JL, Knox K, et al. Review of community pharmacy staff educational needs for supporting mental health consumers and careers. Community Ment Health J. 2014;50(1):59-67.
35. Rubio-Valera M, Chen TF, O’Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967-10990.
36. Health Education England. Framework of core mental health competencies for all pharmacy professionals. 2020;1(December):1-12. Framework 2020.pdf
37. Roth McClurg M, Sorensen TD, Carroll J. The Patient Care Process for Delivering Comprehensive Medication Management (CMM: Optimizing Medication Use in Patient-Centered, Team-Based Care Settings. CMM in Primary Care Research Team. July 2018.
38. Hasan S, Sulieman H, Chapman CB, et al. Community pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2012;20(4):218-225.
39. Svarstad BL, Bultman DC, Mount JK. Patient Counseling Provided in. Research. 2004;44(1):22-29.
40. Dopheide JA, Bostwick JR, Goldstone LW, et al. Curriculum in psychiatry and neurology for pharmacy programs. Am J Pharm Educ. 2017;81(7).
41. Goldstone LW, DiPaula BA, Werremeyer A, et al. The Role of Board-Certified Psychiatric Pharmacists in Expanding Access to Care and Improving Patient Outcomes. Psychiatr Serv. 2021;72(7):794-801.
42. Hasan S. Continuing education needs assessment of pharmacists in the United Arab Emirates. Pharm World Sci. 2009;31(6):670-676.
43. Landers M, Blenkinsopp A, Pollock K, et al. Community pharmacists and depression: the pharmacist as intermediary between patient and physician. Int J Pharm Pract. 2011;10(4):253-265.
44. El Hajj MS, AL-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330-343.
45. Hasan S, Sulieman H, Chapman C, et al. Community pharmacy in the United Arab Emirates: characteristics and workforce issues. Int J Pharm Pract. 2011;19(6):392-399.
46. Zolezzi M, Alamri M, Shaar S, et al. Stigma associated with mental illness and its treatment in the Arab culture: A systematic review. Int J Soc Psychiatry. 2018;64(6):597-609.
47. O’Reilly CL, Bell JS, Chen TF. Consumer-led mental health education for pharmacy students. Am J Pharm Educ. 2010;74(9):167.
48. Buhler A V, Karimi RM. Peer-level patient presenters decrease pharmacy students’ social distance from patients with schizophrenia and clinical depression. Am J Pharm Educ. 2008;72(5):106.

Most read articles by the same author(s)